ItchBio’s lead asset, IB-242, is a topical therapeutic entering a P II trial for the treatment of pruritus in Eczema/Atopic Dermatitis and Psoriasis.
| Website | http://itchbio.com |
| Employees | 2 (0 on RocketReach) |
| Industry | Biotechnology Research |
Looking for a particular ItchBio employee's phone or email?
ItchBio Questions
G2Crowd Trusted
300K+
Plugin Users
